Yet, high levels of tumoural immune infiltrate, particularly higher levels of CD8+ T cells, also predict better responses to traditional chemotherapy (without ICI), including higher rates of pCR, implicating an immune mechanism of action. This evidence concerns the gene CD8A and neoplasm.